MMP9 processing of HSPB1 regulates tumor progression

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and disease.
• Soluble heat shock protein B1 (HSPB1) is released from endothelial cells and regulates angiogenesis by interacting with vascular endothelial growth factor (VEGF).

Purpose of the Study:

• To investigate the role of MMP9 in cleaving HSPB1 and its impact on angiogenesis and tumor progression.
• To identify the functional consequences of HSPB1 fragmentation by MMP9.

Main Methods:

• Mapping of HSPB1 cleavage sites by MMP9.
• In vitro experiments assessing VEGF-induced endothelial cell activation.
• In vivo studies using B16F10 melanoma and CT26 colon carcinoma tumor models in wild-type and MMP9-null mice.

Main Results:

• MMP9 cleaves HSPB1, generating anti-angiogenic fragments.
• HSPB1 cleavage by MMP9 inhibits VEGF-induced endothelial cell activation.
• The C-terminal HSPB1 fragment shows enhanced interaction with VEGF.
• MMP9-mediated HSPB1 cleavage suppresses tumor progression in vivo.
• Intact HSPB1 is more prevalent on tumor endothelium in MMP9-null mice.

Conclusions:

• MMP9-mediated processing of HSPB1 regulates VEGF-induced endothelial cell activation, impacting tumor progression.
• The release of anti-angiogenic HSPB1 fragments by MMP9 plays a key role in controlling tumor growth.
• These findings suggest a potential mechanism for the failure of MMP inhibitors in clinical trials, as inhibiting MMPs might reduce beneficial HSPB1 fragmentation.